Viewing Study NCT01048892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:30 PM
Ignite Modification Date: 2026-01-24 @ 12:35 PM
Study NCT ID: NCT01048892
Status: COMPLETED
Last Update Posted: 2014-01-30
First Post: 2010-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Sponsor: Children's Oncology Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adrenocortical Carcinoma View
None Gastrointestinal Carcinoid Tumor View
None Kidney Cancer View
None Neuroblastoma View
None Retinoblastoma View
None Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent neuroblastoma View
None previously treated childhood rhabdomyosarcoma View
None recurrent childhood rhabdomyosarcoma View
None recurrent Wilms tumor and other childhood kidney tumors View
None recurrent retinoblastoma View
None recurrent adrenocortical carcinoma View
None recurrent gastrointestinal carcinoid tumor View